| Bioactivity | Sprodiamide (Dy-DTPA-BMA) is a susceptibility-based MRI contrast agent that can be used to visualize image intensity changes during vascular transport of drugs[1]. |
| CAS | 128470-17-7 |
| Formula | C16H26DyN5O8 |
| Molar Mass | 578.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lai J J, et al. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of Sprodiamide Injection, a new contrast medium for magnetic resonance imaging[J]. Journal of pharmaceutical and biomedical analysis, 1993, 11(11-12): 1129-1134. |
Sprodiamide
CAS: 128470-17-7 F: C16H26DyN5O8 W: 578.91
Sprodiamide (Dy-DTPA-BMA) is a susceptibility-based MRI contrast agent that can be used to visualize image intensity cha
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.